Weiss Multi-Strategy Advisers’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,127,684
Closed -$12.2M 369
2023
Q4
$12.2M Buy
+1,127,684
New +$13.7M 0.29% 78
2023
Q3
Sell
-92,686
Closed -$1.11M 691
2023
Q2
$1.11M Buy
+92,686
New +$1.05M 0.02% 534
2022
Q4
Sell
-215,073
Closed -$2.51M 708
2022
Q3
$2.51M Sell
215,073
-26,169
-11% -$374K 0.07% 363
2022
Q2
$3.8M Buy
241,242
+170,081
+239% +$2.86M 0.11% 275
2022
Q1
$1.1M Buy
+71,161
New +$898K 0.03% 489
2017
Q4
Sell
-100,734
Closed -$2.11M 642
2017
Q3
$2.11M Buy
100,734
+50,734
+101% +$934K 0.08% 300
2017
Q2
$1.01M Buy
+50,000
New +$1.09M 0.04% 359
2015
Q2
Sell
-93,000
Closed -$1.75M 514
2015
Q1
$1.75M Buy
+93,000
New +$1.59M 0.08% 259
2014
Q2
Sell
-15,140
Closed -$480K 888
2014
Q1
$480K Sell
15,140
-6,030
-28% -$168K 0.01% 677
2013
Q4
$536K Buy
21,170
+2,150
+11% +$51.5K 0.01% 605
2013
Q3
$407K Buy
19,020
+4,679
+33% +$96.1K 0.01% 623
2013
Q2
$278K Buy
+14,341
New +$313K 0.01% 619

Other funds holding PTEN

Weiss Multi-Strategy Advisers's PTEN Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of Patterson-UTI (PTEN) in Q1 2024, closing a stake of 1,127,684 shares — an estimated $12.2M sold.

Weiss Multi-Strategy Advisers first reported a position in PTEN in Q2 2013 and held it in 12 quarters. The position peaked at $12.2M in Q4 2023. 368 funds tracked by Wall St. Rank hold PTEN as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining Patterson-UTI position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 1,127,684 Patterson-UTI shares in Q1 2024, an estimated $12.2M.
  • Weiss Multi-Strategy Advisers first reported a position in Patterson-UTI in Q2 2013 and held it in 12 quarters.
  • Weiss Multi-Strategy Advisers's Patterson-UTI position peaked at $12.2M in Q4 2023.
  • 368 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.